Antibodies from S Africa COVID variant may offer cross-protection

Your video will begin in 10
Skip ad (3)
13 Views
Published
South Africa has received its second batch of 80,000 vaccines donated by Johnson & Johnson.
But there are concerns the roll-out is going more slowly than expected while some critics have described it as a clinical trial.
Al Jazeera's Fahmida Miller reports from Johannesburg, South Africa.
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#AlJazeeraEnglish #SouthAfrica #COVID19
Category
News & Politics
Be the first to comment